OPKO Health, Inc. Gain (Loss) on Disposition of Assets
OPKO Health, Inc. (OPK) reported Gain (Loss) on Disposition of Assets of -$115.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q/A filed 2026-08-28.
Financial Statements › Income Statement › Other Income
us-gaap:GainLossOnDispositionOfAssets1 · last filed 2026-08-28
- OPKO Health, Inc. gain (loss) on disposition of assets for the quarter ending 2026-06-30 was -$149.00K, a 306.94% decline year-over-year.
- OPKO Health, Inc. gain (loss) on disposition of assets for the quarter ending 2026-03-31 was $34.00K, a 99.10% decline year-over-year.
- OPKO Health, Inc. gain (loss) on disposition of assets for the quarter ending 2025-12-31 was -$601.00K, a 101.11% decline year-over-year.
- OPKO Health, Inc. gain (loss) on disposition of assets for the quarter ending 2025-09-30 was -$12.00K, a 100.13% decline year-over-year.
- OPKO Health, Inc. gain (loss) on disposition of assets for fiscal 2025 was $3.25M, a 94.88% decline from fiscal 2024.
- OPKO Health, Inc. gain (loss) on disposition of assets for fiscal 2024 was $63.40M.
- OPKO Health, Inc. gain (loss) on disposition of assets for fiscal 2023 was -$1.32M, a 390.33% decline from fiscal 2022.
- OPKO Health, Inc. gain (loss) on disposition of assets for fiscal 2022 was $455.00K, a 98.66% decline from fiscal 2021.
| Period end | Gain (Loss) on Disposition of Assets 3 month | Gain (Loss) on Disposition of Assets 6 month | Gain (Loss) on Disposition of Assets 9 month | Gain (Loss) on Disposition of Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$149.00K derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2026-08-28 | -$115.00K 10-Q/A · filed 2026-08-28 | -$716.00K derived: sum of 3 quarters · filed 2026-08-28 | -$728.00K derived: sum of 4 quarters · filed 2026-08-28 |
| 2026-03-31 | $34.00K 10-Q/A · filed 2026-08-28 | -$567.00K derived: sum of 2 quarters · filed 2026-08-28 | -$579.00K derived: sum of 3 quarters · filed 2026-08-28 | -$507.00K derived: sum of 4 quarters · filed 2026-08-28 |
| 2025-12-31 | -$601.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$613.00K derived: sum of 2 quarters · filed 2026-02-26 | -$541.00K derived: sum of 3 quarters · filed 2026-08-28 | $3.25M 10-K · filed 2026-02-26 |
| 2025-09-30 | -$12.00K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2025-10-29 | $60.00K derived: sum of 2 quarters · filed 2026-08-28 | $3.85M 10-Q · filed 2025-10-29 | $57.75M derived: sum of 4 quarters · filed 2026-08-28 |
| 2025-06-30 | $72.00K derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2026-08-28 | $3.86M 10-Q/A · filed 2026-08-28 | $57.77M derived: sum of 3 quarters · filed 2026-08-28 | $67.19M derived: sum of 4 quarters · filed 2026-08-28 |
| 2025-03-31 | $3.79M 10-Q/A · filed 2026-08-28 | $57.69M derived: sum of 2 quarters · filed 2026-08-28 | $67.11M derived: sum of 3 quarters · filed 2026-08-28 | $67.14M derived: sum of 4 quarters · filed 2026-08-28 |
| 2024-12-31 | $53.91M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $63.33M derived: sum of 2 quarters · filed 2026-02-26 | $63.35M derived: sum of 3 quarters · filed 2026-02-26 | $63.40M 10-K · filed 2026-02-26 |
| 2024-09-30 | $9.42M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | $9.44M derived: sum of 2 quarters · filed 2025-10-29 | $9.49M 10-Q · filed 2025-10-29 | $9.61M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $22.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | $69.00K 10-Q · filed 2025-07-31 | $192.00K derived: sum of 3 quarters · filed 2026-02-26 | $823.00K derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $47.00K 10-Q · filed 2025-05-01 | $170.00K derived: sum of 2 quarters · filed 2026-02-26 | $801.00K derived: sum of 3 quarters · filed 2026-02-26 | $571.00K derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $123.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $754.00K derived: sum of 2 quarters · filed 2026-02-26 | $524.00K derived: sum of 3 quarters · filed 2026-02-26 | -$1.32M 10-K · filed 2026-02-26 |
| 2023-09-30 | $631.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $401.00K derived: sum of 2 quarters · filed 2024-11-07 | -$1.44M 10-Q · filed 2024-11-07 | -$1.80M derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-06-30 | -$230.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | -$2.08M 10-Q · filed 2024-08-07 | -$2.43M derived: sum of 3 quarters · filed 2025-03-03 | -$2.10M derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-03-31 | -$1.84M 10-Q · filed 2024-05-07 | -$2.20M derived: sum of 2 quarters · filed 2025-03-03 | -$1.87M derived: sum of 3 quarters · filed 2025-03-03 | -$1.33M derived: sum of 4 quarters · filed 2025-03-03 |
| 2022-12-31 | -$359.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | -$22.00K derived: sum of 2 quarters · filed 2025-03-03 | $516.00K derived: sum of 3 quarters · filed 2025-03-03 | $455.00K 10-K · filed 2025-03-03 |
| 2022-09-30 | $337.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | $875.00K derived: sum of 2 quarters · filed 2023-11-06 | $814.00K 10-Q · filed 2023-11-06 | -$748.00K derived: sum of 4 quarters · filed 2024-03-01 |
| 2022-06-30 | $538.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $477.00K 10-Q · filed 2023-08-03 | -$1.08M derived: sum of 3 quarters · filed 2024-03-01 | $31.25M derived: sum of 4 quarters · filed 2024-03-01 |
| 2022-03-31 | -$61.00K 10-Q · filed 2023-05-03 | -$1.62M derived: sum of 2 quarters · filed 2024-03-01 | $30.71M derived: sum of 3 quarters · filed 2024-03-01 | $30.82M derived: sum of 4 quarters · filed 2024-03-01 |
| 2021-12-31 | -$1.56M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-01 | $30.78M derived: sum of 2 quarters · filed 2024-03-01 | $30.88M derived: sum of 3 quarters · filed 2024-03-01 | $33.92M 10-K · filed 2024-03-01 |
| 2021-09-30 | $32.34M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $32.45M derived: sum of 2 quarters · filed 2022-11-08 | $35.48M 10-Q · filed 2022-11-08 | $35.99M derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-06-30 | $107.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $3.15M 10-Q · filed 2022-08-04 | $3.65M derived: sum of 3 quarters · filed 2023-02-27 | $13.98M derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-03-31 | $3.04M 10-Q · filed 2022-05-09 | $3.55M derived: sum of 2 quarters · filed 2023-02-27 | $13.88M derived: sum of 3 quarters · filed 2023-02-27 | $13.82M derived: sum of 4 quarters · filed 2023-02-27 |
| 2020-12-31 | $509.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | $10.84M derived: sum of 2 quarters · filed 2023-02-27 | $10.78M derived: sum of 3 quarters · filed 2023-02-27 | $10.68M 10-K · filed 2023-02-27 |
| 2020-09-30 | $10.33M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-28 | $10.27M derived: sum of 2 quarters · filed 2021-10-28 | $10.17M 10-Q · filed 2021-10-28 | $10.89M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | -$54.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-29 | -$156.00K 10-Q · filed 2021-07-29 | $560.00K derived: sum of 3 quarters · filed 2022-03-01 | -$675.00K derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | -$102.00K 10-Q · filed 2021-04-28 | $614.00K derived: sum of 2 quarters · filed 2022-03-01 | -$621.00K derived: sum of 3 quarters · filed 2022-03-01 | -$557.00K derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | $716.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | -$519.00K derived: sum of 2 quarters · filed 2022-03-01 | -$455.00K derived: sum of 3 quarters · filed 2022-03-01 | -$739.00K 10-K · filed 2022-03-01 |
| 2019-09-30 | -$1.24M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | -$1.17M derived: sum of 2 quarters · filed 2020-10-29 | -$1.46M 10-Q · filed 2020-10-29 | -$1.47M derived: sum of 4 quarters · filed 2021-02-18 |
| 2019-06-30 | $64.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-31 | -$220.00K 10-Q · filed 2020-07-31 | -$232.00K derived: sum of 3 quarters · filed 2021-02-18 | |
| 2019-03-31 | -$284.00K 10-Q · filed 2020-05-06 | -$296.00K derived: sum of 2 quarters · filed 2021-02-18 | ||
| 2018-12-31 | -$12.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-18 | -$46.00K 10-K · filed 2021-02-18 | ||
| 2018-09-30 | -$34.00K 10-Q · filed 2019-11-05 | |||
| 2017-12-31 | $8.66M 10-K · filed 2020-03-02 | |||
| 2016-12-31 | -$2.32M 10-K · filed 2019-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |